FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/04/004558 [Registered on: 23/04/2014] Trial Registered Prospectively
Last Modified On: 20/05/2019
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial, to study whether suction drains placed under the skin, can prevent surgical wound infection in patients undergoing open abdominal surgery for gynecological cancer.  
Scientific Title of Study   A prospective randomised controlled trial investigating the role of subcutaneous suction drain in the prevention of superficial surgical-site infection followng median laparotomy in gynecological oncosurgery.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Suchetha S 
Designation  Associate Professor 
Affiliation  Regional Cancer Centre 
Address  Associate Professor, Division of Surgical Oncology , Regional Cancer Centre, Thiruvananthapuram.

Thiruvananthapuram
KERALA
695011
India 
Phone  9847860868  
Fax  04712447454  
Email  suchethajyothish@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Suchetha S 
Designation  Associate Professor 
Affiliation  Regional Cancer Centre 
Address  Associate Professor, Division of Surgical Oncology , Regional Cancer Centre, Thiruvananthapuram.

Thiruvananthapuram
KERALA
695011
India 
Phone  9847860868  
Fax  04712447454  
Email  suchethajyothish@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Leena Rose Johnson 
Designation  Fellowship Trainee 
Affiliation  Regional Cancer Centre 
Address  Fellowship Trainee, Division of Surgical Oncology , Regional Cancer Centre, Thiruvananthapuram.

Thiruvananthapuram
KERALA
695011
India 
Phone  8289881518  
Fax  04712447454  
Email  leonroop@gmail.com  
 
Source of Monetary or Material Support  
Regional Cancer Centre, Thiruvananthapuram. 
 
Primary Sponsor  
Name  Dr Suchetha S 
Address  Associate Professor, Division of Surgical Oncology Regional Cancer Centre, Thiruvananthapuram  
Type of Sponsor  Other [Principal Investigator] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Leena Rose Johnson  Fellowship trainee, Division of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Suchetha S  Regional Cancer Centre, Thiruvananthapuram Kerala   Division of Surgical oncolgy Regional cancer centre,
Thiruvananthapuram
KERALA 
9847860868
04712447454
suchethajyothish@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Human Ethics Committee, Regional Cancer Centre, Thiruvananthapuram Kerala   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: T814||Infection following a procedure, (2) ICD-10 Condition: C51-C58||Malignant neoplasms of female genital organs, Superficial Surgical Site Infection.,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  No subcutaneous drain   No placement of subcutaneous suction drain at the time of wound closure 
Intervention  With subcutaneous drain  Placement of subcutaneous suction drain no:14 at the time of laparotomy wound closure 
 
Inclusion Criteria  
Age From  14.00 Year(s)
Age To  90.00 Year(s)
Gender  Female 
Details  -Patients undergoing elective laparotomy by midline vertical incision for confirmed or suspected gynecological cancer.
-Subcutaneous fat thickness >2cm, as measured intra-operatively
 
 
ExclusionCriteria 
Details  Immediate re-laparotomy
-Mesh repair
- Clean wounds.A clean wound is an uninfected operative wound in which no infl ammation is encountered
and the respiratory,alimentary,genital,or uninfected urinary tract is not entered. In addition, clean wounds are primarily closed and, if necessary,drained with closed drainage..
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking
Modification(s)  
Open Label 
Primary Outcome  
Outcome  TimePoints 
The incidence of superficial surgical site infection as defined by Center for Disease Control and Prevention.   30 days 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="390"
Sample Size from India="390" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   23/04/2014 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Other (Terminated) 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  

This is a prospective randomised controlled trial on patients who underwent elective laparotomy for suspected or confirmed gynaecological cancer at a gynaecologic oncosurgical unit of a tertiary cancer centre in South India. Patients who underwent surgery through a midline vertical incision with subcutaneous fat thickness >2cm were included in the trial. They were randomised into two arms: the drain arm and the no-drain arm. A subcutaneous closed suction drain was used in the drain arm. The primary outcome measured was the incidence of superficial surgical site infection (s-SSI) as defined by Centers for Disease Control and Prevention.

The study was scheduled to conclude after 15 months. The sample size calculated was 390 patients. However, even after 18 months the required sample size could not be achieved and the study was terminated. 528 patients were screened for the study. Among those who gave informed consent, 308 patients were recruited based on the inclusion and exclusion criteria

 303 patients were available for final analysis, of which 146 were in the ‘drain arm’ and 157 were in the ‘no drain arm’. Overall, 31 patients (10.2%) developed s-SSI. Although the s-SSI incidence was higher in the no- drain arm compared to the drain arm (13.4% versus 6.8%), the difference was not statistically significant (p: 0.087).

 In the subgroup of 47 patients with subcutaneous fat thickness >5 cm, only 1 (4%) patient in the drain arm developed s-SSI, as compared to 9 (40.9%) in the no-drain arm (p value - 0.003). This difference is statistically significant, with subjects in the drain arm 0.06 times likely to develop s-SSI as compared to those in the no-drain arm (OR(95% CI): 0.06 (0.001-0.54)).

This study reveals that subcutaneous suction drains are beneficial in preventing s-SSI only among subjects with subcutaneous fat thickness greater than 5 cm.

 


 
Close